TrademarksHub.

UAE trademark · No. 394095

SKINVIVE BY JUVEDERM — UAE trademark

status
Registered
class
5 · Pharmaceuticals & medical preparations
filed
14 Mar 2023
SKINVIVE BY JUVEDERM — UAE trademark, Class 5, No. 394095
Registered

Renewal window: 14 March 2032 to 14 March 2033 (+6 months grace at a higher fee).

Trademark details

MarkSKINVIVE BY JUVEDERM
Application number394095
Registration number394095
ClassClass 5 Pharmaceuticals & medical preparations
StatusRegistered
Filing date14 March 2023
Published31 August 2023 · Bulletin No. 277
Registered28 October 2023
Expires / renewal due14 March 2033

About this trademark

“SKINVIVE BY JUVEDERM” is a trademark on the UAE register, filed on 14 March 2023 under application number 394095.

It covers Class 5 (Pharmaceuticals & medical preparations).

It was accepted and published in the UAE Trademark Bulletin No. 277 on 31 August 2023.

It was registered on 28 October 2023.

The registration runs until 14 March 2033 — 10 years from filing — and can be renewed in the last year before that date.

Goods and services

As filed with the Ministry of Economy and Tourism (in Arabic). Protection covers only what is listed.

المستحضرات الصيدلانية لعلاج الخطوط القطبية وتجاعيد الوجه وعدم التناسق وعيوب وحالات جلد الإنسان ؛ الغرسات الجلدية البيولوجية ، وهي م حاليل التكميل اللزجة لملء التجاعيد

Mark description: كلمةSKINVIVE باحرف لاتينية ويدنوها العبارةBY JUVEDERM باحرف لاتينية و في الاعلى رسم لشكل قطرة و بداخلها الحرف اللاتينيS بشكل مميز

Gazette history

  • Accepted and published for opposition · No. 27731 August 2023
  • Registered · No. 28131 October 2023

Similar UAE trademarks

Similar by name. See all similar marks · Check your own name

Explore

Class 5 explainedClass 5 marks open for opposition Status check

Source: UAE Trademark Bulletin (Ministry of Economy and Tourism) as read by TrademarksHub; renewal date worked out from the filing date. Trademark data only — owner details are not published on this site. Check the official register before acting. Not legal advice.